FLG2 and Alzheimer disease: It has been discussed how mutations in FLG, FATP4 and TMEM79 genes and increase in SC pH converge to produce defective lamellar body and/or to impair the secretion of these structures in patients with AD.17 Mutations in FLG2 and reduced expression of filaggrin-2 may well be involved.